Last updated: July 6, 2021
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting
Phase
4
Condition
Obsessive-compulsive Disorder
Kleptomania
Anxiety Disorders
Treatment
N/AClinical Study ID
NCT04963257
2019-234
Ages 12-45 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The Diagnostic criteria of OCD in the Diagnostic and Statistical Manual of MentalDisorders 5th edition (DSM-V), as well as the definition of refractory OCD, are asfollows: failure to respond to oral treatment with at least two effective doses ofantidepressants, including: Fluoxetine (≥20mg/ d), fluvoxamine (≥200mg/d), sertraline (≥150mg/d), and paroxetine (≥ 40mg/d) were all treated for at least 12 weeks. TheYale-Brown compulsive scale (Y-BOCS) score decreased by < 35%.
- The total score of Yale- Brown compulsion scale (Y-BOCS) ≥16 points. (3)age 12 ~ 45years.
Exclusion
Exclusion Criteria:
- Exclusion of severe organic brain disease;
- Severe physical illness;
- Other mental disorders such as tics, disruptive disorders, eating disorders and autismspectrum disorders;
- Pediatric streptococcal infection causedby autoimmune neuropsychiatric disease (PANDAS);
- Alcohol and drug dependence; Angle-closure glaucoma;
- Suicidal tendencies;
- Previous history of drug allergies related to research;
- Pregnant and lactating women.
Study Design
Total Participants: 400
Study Start date:
January 01, 2020
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
The Fourth Affiliated Hospital of Zhejiang University Medical College
Yiwu, Zhejiang
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.